Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. - Wikidata - awgldk - TriplyDB

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.

http://www.wikidata.org/entity/Q45864372

about

Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients How I treat acquired aplastic anemia Alternative donor transplant of benign primary hematologic disorders Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review.Chronic graft-versus-host disease (GVHD) in children.First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy New advances in hematopoietic cell transplantation Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis Favorable preliminary results using TLI/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia.Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the field Success of allogeneic marrow transplantation for children with severe aplastic anaemia.Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.Myelodysplasia and acute leukemia as late complications of marrow failure: future prospects for leukemia prevention.Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia.How I manage aplastic anaemia in children.Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.Current management of severe acquired aplastic anemia.High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.Matched sibling donors versus alternative donors in allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia in México.Costs and consequences of immunosuppressive therapy in children with aplastic anemia.Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients.Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.Outcome of pediatric acquired aplastic anemia: a developing world experience.Improved outcome of haploidentical transplantation in severe aplastic anemia using reduced-intensity fludarabine-based conditioning.Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.Implications of CD34+ cell dose on clinical and haematological outcome of allo-SCT for acquired aplastic anaemia.Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia.Unrelated donor cord blood transplantation for non-malignant disorders in children and adolescents.Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia

P2860

Q24187102-5EBA2CE8-B60B-4A63-9104-9ABE106629E9 Q24187108-F91F5075-BE27-452D-BFC1-825AA6C0AB0F Q24200272-9FE77CA6-A892-402D-9502-9B69BE6E7491 Q24200282-E8E514BB-EDA0-427A-94C8-C4057EC0F389 Q24200648-C30183D3-1D08-451B-9F77-AE34A95AE923 Q24202963-E92D3B6C-5AC8-49EF-A56E-D9AFD2BFF05B Q24617687-15F49E31-BDDD-4A83-BC6D-FC7ADE81C1CE Q26823398-58788DB7-A297-4744-8EF5-1F56D1D0ED15 Q33489272-03CC1320-E94E-45CC-A6E2-3C8207F90AD7 Q33857680-E287A299-4457-48CC-A51A-CCE3DC1A58ED Q34649082-454F05BB-A924-4C43-B98C-D2B690F663F9 Q35213018-70888BFB-7B27-4C39-9FF2-6B3D865A0DF2 Q35571068-A596C689-2D23-4C74-A0FF-D42984AC6E83 Q36514033-B82E3D17-2B05-4B8C-A574-9D287852B402 Q36909167-23D97420-CB7B-4F86-BA8A-76E7F5E138B3 Q36958013-905F83AE-9499-4C39-85D4-1C32B1A522D2 Q36961081-B1DF4597-8CB8-4540-AC7E-66C866A1E3C1 Q37229440-0DE44AC5-63D4-4201-9D9A-6B6ED0486E04 Q37677193-E1AD0810-B780-4279-9DB7-B06CA5B1423F Q37770210-5DAFF6C6-8862-4C29-8114-790385B39BFA Q37986162-43B53B3D-B5CE-4BEA-867D-0FFDB8C85B33 Q38062303-7B12080A-A6DD-44AA-8D21-CBABB497827F Q38103184-14B4C1F6-7200-4F30-94FC-A73E75880D82 Q38261555-09B8D275-3C2F-416A-8EED-D7B32C51528F Q38694686-5B3BEBE8-9603-4830-8110-A3B384B411DC Q40496183-EAA8805B-9BBE-4CB8-AE8D-77B4D7222193 Q41584606-8E21FF2C-FFA6-40A7-845B-09E1139857FC Q42743020-EF13464F-DB90-46C8-A130-ECD9B570B0F5 Q43143185-F0653F99-C505-4863-993F-36A79E4D7D6D Q43445845-E67E4441-C5FB-46D5-A7DF-E71E89B51359 Q44385094-D97B16B3-3AF3-407E-BE20-3E4E5029FDD8 Q46768308-6F5A30E6-0C76-43C4-98B1-18F6139D77C9 Q47126486-95C8A815-9A84-4166-AC0E-34BA5C83C6B1 Q47865904-CC6F0F32-23AD-4CD3-A5D0-65367EDDC967 Q50595454-E8D9B239-9752-4C57-8DE6-CBE365723479 Q53460735-F2CC933E-B139-4DFA-BD2E-ABD07E27028C Q54392397-7AC8D8F5-1B63-4777-ACB7-229529D7422D Q58449850-5E8614C9-4150-4E15-B872-4BA4F8D502F8

P2860

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.

http://www.wikidata.org/entity/Q45864372

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Comparable outcomes of matched ...... iatric severe aplastic anemia.

@en

Comparable outcomes of matched ...... iatric severe aplastic anemia.

@nl

type

label

Comparable outcomes of matched ...... iatric severe aplastic anemia.

@en

Comparable outcomes of matched ...... iatric severe aplastic anemia.

@nl

prefLabel

Comparable outcomes of matched ...... iatric severe aplastic anemia.

@en

Comparable outcomes of matched ...... iatric severe aplastic anemia.

@nl

P1433

Q45864372-13A3C10E-2494-4D8A-BFE0-8F9643B125A7

P1476

Q45864372-464D54CA-A2DA-4C96-B5C9-D7FDD6D6E982

P2093

Q45864372-225832A2-6D40-4BF0-9AA4-2CC6F3A20C44

Q45864372-58D076C2-54ED-4E6C-A6BD-DDE191C5EDAB

Q45864372-63E24559-7657-48A5-A9BC-C0FA581960F1

Q45864372-652FB2FD-751F-4D2A-94AD-D9991673E674

Q45864372-7CAAC564-E359-4102-91E5-E4E35F4E6F75

Q45864372-90BB6C26-C9AC-472F-9E6F-FB4420F8FA07

Q45864372-A98A594C-DD70-4368-B4C0-B804C3092401

Q45864372-E71555F8-65B2-4937-8443-09D8B1CEE664

Q45864372-ED546B61-D0C0-4B7F-B4FF-BECFF48D797B

Q45864372-F6C741E4-0FBA-4CFF-96BF-F2BD3F99CFFF

P304

Q45864372-AAA4C20C-F344-4EA8-9389-213DEFF465A4

P31

Q45864372-6F1CAE3B-87DD-4642-9CBA-240D9C2A9262

P356

Q45864372-A4B3194C-14CC-4EC8-A0AB-E0CA4D414711

P433

Q45864372-11AFE8F5-BBCA-4EE6-A3CC-6AEC30DFBC34

P478

Q45864372-E5AFDE3A-9812-4EAD-B74A-F9BD10F326B9

P577

Q45864372-D07C5A56-8E19-49EB-A54C-72906DEA5AE7

P5875

Q45864372-F028F922-6B1C-4933-AAED-FA9882171409

P698

Q45864372-5CE49344-1CB5-4070-B314-4D3B81201DEC

P356

J.BBMT.2006.07.011

P1433

Biology of Blood and Marrow Transplantation

P1476

Comparable outcomes of matched ...... iatric severe aplastic anemia.

@en

P2093

Alana A Kennedy-Nasser

http://www.w3.org/2001/XMLSchema#string

Anita Mahajan

http://www.w3.org/2001/XMLSchema#string

Catherine M Bollard

http://www.w3.org/2001/XMLSchema#string

George Carrum

http://www.w3.org/2001/XMLSchema#string

Heidi L Weiss

http://www.w3.org/2001/XMLSchema#string

Helen E Heslop

http://www.w3.org/2001/XMLSchema#string

James A Arce

http://www.w3.org/2001/XMLSchema#string

Kathryn S Leung

http://www.w3.org/2001/XMLSchema#string

Malcolm K Brenner

http://www.w3.org/2001/XMLSchema#string

Robert A Krance

http://www.w3.org/2001/XMLSchema#string

P304

1277-1284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2006.07.011

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6637966

http://www.w3.org/2001/XMLSchema#string

P698

17162209

http://www.w3.org/2001/XMLSchema#string